LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

Characterization of mAb Aggregation

 

Similar PDF

Toggle
The Analysis of Multimeric Monoclonal Antibody Aggregates by Size-Exclusion UPLC Stephan Koza, Matthew Lauber, and Kenneth J. Fountain Waters Corporation, Milford, MA, USA A P P L I C AT I O N B E N E F I T…
Key words
multimeric, multimericmultimers, multimersdimer, dimeraggregates, aggregatesuplc, uplctrimer, trimermonoclonal, monoclonalexclusion, exclusiondimeric, dimericmonomer, monomermab, mabantibody, antibodysize, sizeaggregate, aggregateforms
High-throughput and Sensitive Size Exclusion Chromatography (SEC) of Biologics Using Agilent AdvanceBio SEC Columns Agilent AdvanceBio SEC 300 Å, 2.7 µm columns Application note Bio-Pharmaceutical Author Abstract M. Sundaram Palaniswamy Monoclonal antibody (mAb) aggregation can arise due to multiple mechanisms…
Key words
herceptin, herceptinadc, adcmau, mauadvancebio, advancebiosec, secmonomer, monomeraggregate, aggregatemab, maboverlay, overlayaggregates, aggregatesstressed, stressedreplicates, replicatesdegraded, degradedpreservative, preservativecolumns
Agilent Biocolumns Aggregate/Fragment Analysis Application Compendium Contents Background 2 Getting Started 3 How to Guide - Size Exclusion Chromatography for Biomolecule Analysis - 5991-3651EN 4 Featured Application Notes Elevate Your mAb Aggregate Analysis - 5994-2709EN 1 22 22 High-Resolution, High-Throughput…
Key words
return, returnsection, sectioncontents, contentsmau, mausec, secinsulin, insulinmin, minsize, sizeprotein, proteinmonomer, monomeradvancebio, advancebiotime, timeexclusion, exclusionaggregates, aggregatesaggregate
Separate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC The Agilent 1260 Infinity Bio-Inert Quaternary LC System and the AdvanceBio SEC 300Å, 2.7 µm Column Application Note Biologics and Biosimilars Author Abstract M.Sundaram Palaniswamy Monoclonal antibody aggregation can arise…
Key words
aggregates, aggregatesinnovator, innovatorbiosimilar, biosimilarrituximab, rituximabfragments, fragmentsintact, intactmau, mausec, secstressed, stressedmabs, mabsstress, stressadvancebio, advancebiomonomer, monomerarea, areaaggregation
Other projects
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike